Advances in immunotoxins.
The field of immunotoxins is continuing to grow, as shown by the increase in attendance (175 vs. 145) and abstracts (110 vs. 60) at the symposium. Advances in the molecular biology of the toxins and clinical applications were notable at this meeting. The next 2 years should see better definition of the mechanism of action of peptide toxins as well as improvements in the design of targeted toxins for potential therapy of a wide variety of human diseases.
Oeltmann
T N
TN
Department of Medicine, Vanderbilt Medical School, Nashville, Tennessee 37232.
Frankel
A E
AE
D000911:Antibodies, Monoclonal / Q000493:pharmacokinetics; D001427:Bacterial Toxins / Q000493:pharmacokinetics; D004705:Endocytosis; D000922:Immunotoxins / Q000493:pharmacokinetics*; D012276:Ricin / Q000493:pharmacokinetics
D000911:Antibodies, Monoclonal; D001427:Bacterial Toxins; D000922:Immunotoxins; D012276:Ricin